Cookies?
Library Header Image
LSE Research Online LSE Library Services

Items where Author is "Wang, Nan"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 4.

Mt-Isa, Shahrul, Hallgreen, Christine E., Wang, Nan, Callréus, Torbjörn, Genov, Georgy, Hirsch, Ian, Hobbiger, Stephen F., Hockley, Kimberley S., Luciani, Davide, Phillips, Lawrence D., Quartey, George, Sarac, Sinan B., Stoeckert, Isabelle, Tzoulaki, Ioanna, Micaleff, Alain and Ashby, Deborah (2014) Balancing benefit and risk of medicines: a systematic review and classification of available methodologies. Pharmacoepidemiology and Drug Safety, 23 (7). pp. 667-678. ISSN 1053-8569

Micaleff, Alain, Callreus, Tornbjorn, Phillips, Lawrence D., Hughes, Diana, Hockley, Kimberley, Wang, Nan and Luciani, David (2013) IMI work package 5: report 1:b:iii benefit - riskwave 1 case study report:Raptiva® (efalizumab). . PROTECT Consortium, London.

Phillips, Lawrence D., Amzal, Billy, Asiimwe, Alex, Chan, Edmond, Chen, Chen, Hughes, Diana, Juhaeri, Juhaeri, Micaleff, Alain, Mt-Isa, Shahrul, Noel, Becky, Shepherd, Susan and Wang, Nan (2013) IMI work package 5: report 2:b:ii benefit - riskwave 2 case study report: Rosiglitazone. . PROTECT Consortium, London.

Mt-Isa, Shahrul, Peters, Ruth, Phillips, Lawrence D., Chan, Kakit, Hockley, Kimberley S., Wang, Nan, Ashby, Deborah and Tzoulak, Ioanna (2013) Review of visualisation methods for therepresentation of benefit-risk assessment ofmedication: Stage 1 of 2. . PROTECT Consortium, London.

This list was generated on Tue Nov 19 05:39:01 2019 GMT.